A detailed history of Cromwell Holdings LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Cromwell Holdings LLC holds 6 shares of UTHR stock, worth $2,798. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6
Previous 6 -0.0%
Holding current value
$2,798
Previous $1,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 21, 2025

BUY
$276.47 - $328.4 $1,105 - $1,313
4 Added 200.0%
6 $1,000
Q1 2025

Apr 30, 2025

BUY
$304.42 - $380.78 $608 - $761
2 New
2 $0

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $21.2B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Cromwell Holdings LLC Portfolio

Follow Cromwell Holdings LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cromwell Holdings LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cromwell Holdings LLC with notifications on news.